6.130 USD  -0.070 (-1.13%)
Streaming Delayed Price  /  Updated: 2:07 PM EDT, Apr 23, 2014  /  Add to My Watchlist      
(ALIM) Community Analysis from
April 23, 2014
Courtesy of Benzinga. Alimera Sciences (NASDAQ: ALIM) received a CRL from the FDA today, as the agency rejected Iluvien, a drug [...]
(Penny Stock DD, 12/24/10)
ATLANTA, Dec. 23, 2010 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq:ALIM) ("Alimera"), a biopharmaceutical company that...(read more)
(Benzinga, 10/14/10)
Alimera Sciences, Inc. (Nasdaq: ALIM) announced today that it has obtained a $32.5 million senior secured credit facility to help fund its working capital requirements. The credit facility consists of a $20 million revolving line of...(read more)
Alimera Sciences (ALIM) Company Overview

There is no analysis for ALIM yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here